bioAffinity Technologies, Inc. (BIAFW) — Cash & Equivalents

Annual figures by fiscal year, from SEC filings.

2021: $1.36M2022: $11.41M2023: $2.82M2024: $1.11M2025: $6.45M$6.45M
2021Cash & Equivalents (USD)2025
Fiscal YearCash & EquivalentsChange YoY
2025$6.45M+483.5%
2024$1.11M-60.8%
2023$2.82M-75.3%
2022$11.41M+738.9%
2021$1.36M